• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
• 3. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 4. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 5. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Hydroxyquinolines

Professional Introduction to 3-Hydroxyquinoline-6-Carbonitrile (CAS No. 63124-12-9)

3-hydroxyquinoline-6-carbonitrile is a versatile heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. With the CAS number 63124-12-9, this compound serves as a crucial intermediate in the synthesis of various bioactive molecules, particularly those with potential therapeutic applications. Its unique structural framework, featuring both hydroxyl and nitrile functional groups, makes it a valuable scaffold for drug discovery and development.

The chemical structure of 3-hydroxyquinoline-6-carbonitrile consists of a quinoline core substituted at the 3-position with a hydroxyl group and at the 6-position with a nitrile group. This arrangement imparts distinct electronic and steric properties to the molecule, influencing its reactivity and interaction with biological targets. The presence of both polar functional groups enhances its solubility in polar solvents, facilitating its use in various synthetic protocols and biological assays.

In recent years, 3-hydroxyquinoline-6-carbonitrile has been extensively studied for its pharmacological properties. Research has demonstrated its potential as a precursor in the synthesis of compounds with antimicrobial, anti-inflammatory, and anticancer activities. The quinoline scaffold is well-known for its biological significance, with several FDA-approved drugs featuring this core structure. The introduction of additional functional groups, such as the hydroxyl and nitrile moieties, further expands its pharmacological spectrum.

One of the most compelling aspects of 3-hydroxyquinoline-6-carbonitrile is its role in the development of novel antimicrobial agents. The increasing prevalence of antibiotic-resistant pathogens has necessitated the discovery of new therapeutic strategies. Quinoline derivatives have long been recognized for their efficacy against bacterial and viral infections. The modifications introduced by the hydroxyl and nitrile groups enhance the compound's ability to interact with microbial enzymes and receptors, potentially leading to more effective treatments.

The hydroxyl group at the 3-position of 3-hydroxyquinoline-6-carbonitrile plays a critical role in modulating its biological activity. This functional group can participate in hydrogen bonding interactions with biological targets, thereby influencing the compound's binding affinity and selectivity. Additionally, the nitrile group at the 6-position contributes to the molecule's reactivity, allowing for further derivatization and customization to tailor specific pharmacological properties.

Recent advancements in computational chemistry have enabled more efficient screening and design of bioactive molecules derived from 3-hydroxyquinoline-6-carbonitrile. Molecular modeling techniques have been employed to predict the binding modes of this compound with various biological targets, including enzymes and receptors involved in pathogenic processes. These studies have provided valuable insights into optimizing the structure-activity relationships (SAR) of quinoline derivatives.

The synthesis of 3-hydroxyquinoline-6-carbonitrile involves multi-step organic transformations that highlight its synthetic utility. Common synthetic routes include condensation reactions between appropriate precursors followed by functional group modifications. The availability of high-quality starting materials and efficient synthetic methodologies has made it feasible to produce this compound on both laboratory and industrial scales.

In conclusion, 3-hydroxyquinoline-6-carbonitrile (CAS No. 63124-12-9) is a multifaceted compound with significant potential in pharmaceutical research and drug development. Its unique structural features and biological activities make it a valuable scaffold for designing novel therapeutic agents. Ongoing research continues to uncover new applications and derivatives of this compound, reinforcing its importance in modern medicinal chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)